Related Experiment Video
Updated: Mar 19, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Linking autophagy with inflammation through IRF1 signaling in ER+ breast cancer
Katherine L Cook1, Jessica L Schwartz-Roberts2, William T Baumann3
1Department of Oncology and Lombardi Comprehensive Cancer Center; Georgetown University Medical Center, Washington, DC USA; Department of Surgery, Hypertension and Vascular Research Center, Wake Forest Comprehensive Cancer Center; Wake Forest University, Winston-Salem, NC USA.
Abstract:
Resistance to antiestrogen therapy remains a critical determinant of mortality in patients affected by ER+ breast cancer. Our previous work identified autophagy and interferon regulatory factor 1 (IRF1) signaling as key regulators of this process. We have recently demonstrated a novel reciprocal interaction between IRF1 and ATG7, linking inflammation and autophagy.
Related Concept Videos
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Regulation of the Unfolded Protein Response
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

